Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/04/21 09:32:55」(JST)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 収縮能障害による心不全における生存期間の予測 predictors of survival in heart failure due to systolic dysfunction
2. 心不全の予後 prognosis of heart failure
3. 心不全における心臓再同期療法：適応 cardiac resynchronization therapy in heart failure indications
4. 最新の診療アップデート practice changing updates
5. 心不全または心筋症患者の病因及び重症度の決定 determining the etiology and severity of heart failure or cardiomyopathy

Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.

Paraskevaidis IA, Ikonomidis I, Parissis J, Papadopoulos C, Stassinos V, Bistola V, Anastasiou-Nana M.AbstractBACKGROUND: We investigated whether dobutamine-induced changes of the left atrial (LA) two-dimensional speckle tracking parameters are related to clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensate chronic heart failure (ADCHF).
International journal of cardiology.Int J Cardiol.2012 May 17;157(1):31-7. Epub 2010 Dec 22.
BACKGROUND: We investigated whether dobutamine-induced changes of the left atrial (LA) two-dimensional speckle tracking parameters are related to clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensate chronic heart failure (ADCHF).METHODS: Forty-six
PMID 21176979

Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy.

Masci PG, Barison A, Aquaro GD, Pingitore A, Mariotti R, Balbarini A, Passino C, Lombardi M, Emdin M.SourceFondazione "G. Monasterio" CNR - Regione Toscana, Pisa, Italy.
International journal of cardiology.Int J Cardiol.2012 May 17;157(1):43-7. Epub 2010 Dec 21.
OBJECTIVES: We investigated the prognostic role of myocardial fibrosis by delayed enhancement (DE) cardiovascular magnetic resonance (CMR) in nonischemic dilated cardiomyopathy (NICM) patients with no or mild symptoms of heart failure (HF).METHODS: A prospective cohort of 125 NICM patients (82 males
PMID 21176853

Depression and Outcomes in Hospitalized Japanese Patients With Cardiovascular Disease : Prospective Single-Center Observational Study

SUZUKI Tsuyoshi,SHIGA Tsuyoshi,KUWAHARA Kazue,KOBAYASHI Sayaka,SUZUKI Shinichi,NISHIMURA Katsuji,SUZUKI Atsushi,OMORI Hisako,MORI Fumiaki,ISHIGOOKA Jun,KASANUKI Hiroshi,HAGIWARA Nobuhisa
Circulation journal : official journal of the Japanese Circulation Society 75(10), 2465-2473, 2011-09-25
… 47% New York Heart Association [NYHA] class II-IV; … NYHA class III/IV, defibrillator implantation, and being unmarried were independently associated with depression. …
NAID 10029459801

リンク元	「New York Heart Association」
拡張検索	「NYHA心機能分類」

NYHA心機能分類 : 約 19,600 件
NYHA分類 : 約 5,730 件

クラス	自覚症状
I	身体活動を制限する必要はない心疾患患者。通常の身体活動で，疲労，動悸，息切れ，狭心症状が起こらない。
II	身体活動を軽度ないし中等度に制限する必要のある心疾患患者。通常の身体活動で，疲労，動悸，息切れ，狭心症状が起こる。
III	身体活動を高度に制限する必要のある心疾患患者。安静時には何の愁訴もないが，普通以下の身体活動でも疲労，動悸，息切れ，狭心症状が起こる。
IV	身体活動の大部分を制限せざるをえない心疾患患者。安静にしていても心不全症状や狭心症状が起こり，少しでも身体活動を行うと症状が増強する。

NYHA Class	Symptoms
I	Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.
II	Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.
III	Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest.
IV	Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients.